<DOC>
	<DOCNO>NCT00660192</DOCNO>
	<brief_summary>The hypothesis study injection botulinum toxin A muscle around head ( frontal , temporal , posterior neck , occipital ) reduce intensity frequency migraine headaches 50 % .</brief_summary>
	<brief_title>Investigation Efficacy Safety Botulinum Toxin A ( Botox-Allergan Inc ) Migraine Headaches</brief_title>
	<detailed_description>Contact PI study detail</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Adults 18 old Migraine three month , fail respond two major antimigraine drug , meet criterion chronic migraine Age 18 Pregnant may become pregnant Disease neuromuscular junction drug affect NM junction Allergy Botox Previous use Botox migraine similar methodology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Migraine , refractory migraine , Pain , Botulinum Toxin , Botox</keyword>
</DOC>